Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
6.19M
-
Shares change
-
-1.06M
-
Total reported value, excl. options
-
$19.9M
-
Value change
-
-$5.85M
-
Put/Call ratio
-
0.82
-
Number of buys
-
24
-
Number of sells
-
-33
-
Price
-
$3.21
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q3 2022
82 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q3 2022.
Co-Diagnostics, Inc. - Common Stock (CODX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.19M shares
of 38.5M outstanding shares and own 16.06% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.6M shares), RENAISSANCE TECHNOLOGIES LLC (705K shares), BlackRock Inc. (540K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (438K shares), MORGAN STANLEY (380K shares), GEODE CAPITAL MANAGEMENT, LLC (305K shares), Bank of New York Mellon Corp (238K shares), AMERICAN CENTURY COMPANIES INC (186K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (160K shares), and Walleye Capital LLC (137K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.